mitiglinide

Trade name: Glufast

Small moleculeexperimental

Mitiglinide is a drug for the treatment of type 2 diabetes. — Wikipedia

Chemistry & pharmacology

Loading structure…

SMILES

O=C(O)[C@H](CC(=O)N1C[C@H]2CCCC[C@H]2C1)Cc1ccccc1
Mol. weight
315.41 g/mol
Lipinski Ro5
Pass
Rule of 3
No
Chirality
Single Stereoisomer
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • 2-benzyl-3-(hexahydro-2-isoindolinylcarbonyl)propionate
  • 2h-isoindole-2-butanoic acid, octahydro-gamma-oxo-alpha-(phenylmethyl)-, calcium salt, (2(s)-cis)-
  • calcium 2-benzyl-3-(cis-hexahydro-2-isoindolinylcarbonyl)propionate dihydrate
  • insulin secretagogue
  • kad 1229
  • kad-1229
  • kad-1229
  • kad-1229
  • kad-1229
  • mitiglinide
  • mitiglinide
  • mitiglinide
  • mitiglinide
  • mitiglinide
  • mitiglinide
  • mitiglinide
  • mitiglinide
  • mitiglinide
  • miti-glinide
  • mitiglinide calcium
  • mitiglinide calcium
  • mitiglinide calcium dihydrate
  • mitiglinide calcium hydrate
  • mitiglinide calcium hydrate
  • s21403
  • s 21403

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT02503943Phase 4May 1, 2015People's Liberation Army of China
NCT02154347Phase 4May 30, 2014Kissei Pharmaceuticals
NCT02143765Phase 4May 1, 2014Southeast University
NCT04349696Phase 4Feb 11, 2014Chang Gung University, Orient Europharma Co., Ltd., Taipei Veteran General hospital
NCT02088918Phase 1Oct 1, 2012IlDong Pharmaceutical Co Ltd
NCT01456130Phase 3Nov 1, 2011Takeda
NCT01403818Phase 1Jun 1, 2011Astellas
NCT01333592Phase 3Apr 6, 2011Kissei Pharmaceuticals
NCT01443221Phase 1Dec 1, 2010JW Pharmaceutical, Sungkyunkwan University
NCT01422590Phase 1May 1, 2010JW Pharmaceutical, Sungkyunkwan University
NCT00663884Phase 4Feb 1, 2008Catholic University of Korea, JW Pharmaceutical
NCT00519142Phase 3Aug 1, 2007Elixir Pharmaceuticals
NCT01037842Phase 3Aug 1, 2006Catholic University of Korea, Chonbuk National University, Chonnam National University, Chungnam National University, Eulji University, Hallym University, Korea University, Kyungpook University, Pusan National University, Seoul National University, Sungkyunkwan University, Yonsei University
NCT00461617Phase 3Aug 1, 2006Fudan University, Kissei Pharmaceuticals
NCT00174642Phase 3Dec 1, 2004Sanofi
NCT00369148Phase 4Jul 1, 2004Keio University, Saiseikai Central Hospital
Showing 16 of 16 trials
Page 1 / 1

Organizations

Research & Development (27)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
JW PharmaceuticalFor profit3222008
Kissei PharmaceuticalsFor profit3322006
Sungkyunkwan UniversityAcademic/Hospital3122006
Catholic University of KoreaAcademic/Hospital2022006
AstellasFor profit1112011
Chang Gung UniversityAcademic/Hospital1012014
Chonbuk National UniversityAcademic/Hospital1012006
Chonnam National UniversityAcademic/Hospital1012006
Chungnam National UniversityAcademic/Hospital1012006
Elixir PharmaceuticalsFor profit1112007
Eulji UniversityAcademic/Hospital1012006
Fudan UniversityAcademic/Hospital1012006
Hallym UniversityAcademic/Hospital1012006
IlDong Pharmaceutical Co LtdFor profit1112012
Keio UniversityAcademic/Hospital1112004
Korea UniversityAcademic/Hospital1012006
Kyungpook UniversityAcademic/Hospital1012006
Orient Europharma Co., Ltd.For profit1112014
People's Liberation Army of ChinaGovernment1112015
Pusan National UniversityAcademic/Hospital1012006
27 organizations
Page 1 / 2